Skip to main content
FinSpry Logo
FinSpry
JNJ logo
JNJ
(NYSE)
Johnson & Johnson
$230.00-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Johnson & Johnson (JNJ) Stock Price & Financial Analysis

Johnson & Johnson Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$228.04 - $230.85
52-Week High$251.71
52-Week Low$146.12
Open$228.94
Volume7.70M
Average Volume (3M)7.60M
Market Cap554.35B
Shares Outstanding2.45B
P/E Ratio (TTM)26.35
Forward P/E27.67
Price to Sales (P/S)5.75
Price to Book (P/B)6.83
EV/EBITDA17.73
Revenue (TTM)96.36B
Net Income (TTM)21.04B
Free Cash Flow (TTM)17.41B
EPS (TTM)$8.65
Profit Margin21.83%
Operating Margin26.87%
Return on Equity (ROE)25.92%
Debt to Equity0.68
50-Day MA$235.39
200-Day MA$208.26
52-Week Change43.66%
Annual Dividend$5.20
Dividend Yield2.25%
Payout Ratio60.13%
Last Dividend Ex-DateMay 26, 2026

Frequently Asked Questions About Johnson & Johnson

What is the current stock price for JNJ?

As of the latest trading session, JNJ stock trades at $230.00. The 52-week range is $146.12–$251.71, with a day range of $228.04–$230.85.

What is the P/E ratio for JNJ?

Johnson & Johnson's trailing P/E ratio is 26.4, meaning investors pay $26.4 for every $1 of annual earnings. The forward P/E is 27.7, reflecting analyst expectations for future earnings. Johnson & Johnson operates in the Healthcare sector.

Does JNJ pay dividends?

Yes, Johnson & Johnson pays a 2.25% annual dividend yield ($5.20 per share). The payout ratio is 60.1%. The last ex-dividend date was 2026-05-26.

What do analysts recommend for JNJ?

Based on 9 analysts, the consensus for JNJ is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of JNJ?

Johnson & Johnson's market capitalization is $562.40B, classifying it as a mega-cap company. Johnson & Johnson operates in the Healthcare sector within the Drug Manufacturers - General industry.